Displaying drugs 751 - 775 of 811 in total
VB-201
VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).
Investigational
Cordycepin Triphosphate
Experimental
Palmitoyl-Linoleoyl Phosphatidylcholine
Experimental
dATP
Experimental
Deoxycytidylyl-3',5'-guanosine
Experimental
5-fluoro-2'-deoxyuridine-5'-monophosphate
Experimental
5-Iodo-2'-Deoxyuridine-5'-Monophosphate
Experimental
L-Alfa-Lysophosphatidylcholine, Lauroyl
Experimental
4-Hydroxy-L-Threonine-5-Monophosphate
Experimental
2',3'-Dideoxyadenosine triphosphate
Experimental
Platelet Activating Factor
Experimental
Phosphatidylethanolamine
Experimental
1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
Experimental
Di-Stearoyl-3-Sn-Phosphatidylethanolamine
Experimental
Diundecyl Phosphatidyl Choline
Experimental
2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid
Experimental
Di-Stearoyl-3-Sn-Phosphatidylcholine
Experimental
Brivudine monophosphate
Experimental
Fosdagrocorat
Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.
Investigational
BMS-830216
BMS-830216 is under investigation in clinical trial NCT00909766 (Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects).
Investigational
Iproniazid
Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Withdrawn
Matched Salts name: … Iproniazid phosphate …
Phosphonotyrosine
An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. [PubChem]
Experimental
Displaying drugs 751 - 775 of 811 in total